 | |
| Legal status | |
|---|---|
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.233.198 |
| Chemical and physical data | |
| Formula | C22H30N2O2 |
| Molar mass | 354.494 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
A-796,260 is a drug developed byAbbott Laboratories that acts as a potent and selectivecannabinoidCB2receptoragonist. Replacing the aromatic 3-benzoyl or 3-naphthoyl group found in mostindole derived cannabinoids with the 3-tetramethylcyclopropylmethanone group, imparts significant selectivity for CB2, and A-796,260 was found to be a highly selective CB2 agonist with little affinity for CB1, having a CB2Ki of 4.6 nM vs 945 nM at CB1.[1] It has potentanalgesic andanti-inflammatory actions in animal models, being especially effective in models ofneuropathic pain, but without producing cannabis-like behavioral effects.[2]
As of October 2015 A-796,260 is a controlled substance in China.[3]
 | Thiscannabinoid related article is astub. You can help Wikipedia byexpanding it. |